Hyderabad, India — January 28, 2013 — GVK Biosciences (GVK BIO), Asia’s leading drug discovery research and development CRO announced today that it has entered…
News Category: Press Release
GVK Biosciences and Onconova Therapeutics Establish a Novel Joint Development Partnership to Advance New Drugs for Cancer
Hyderabad, India; Newtown, PA, USA — January 09, 2013 — GVK BIO, Asia’s leading Contract Research and Development organization and Onconova Therapeutics, a U.S. based…
GVK BIO Establishes the Largest Isotope Labeling Facility in India
GVK Biosciences (GVK BIO), Asia’s leading Drug Discovery Research & Development organization, has received approvals from the Atomic Energy Regulatory Board (AERB), Government of India,…
GVK Biosciences Licenses its Biomarker Database to The Division of Cancer Prevention, National Cancer Institute
Hyderabad, India — September 04, 2012 — GVK Biosciences (GVK BIO), Asia’s leading contract research organization announced today that it has licensed its popular clinical…
BioAsia 2012 from February 09; GVK Biosciences is Co-Industry Host
Hyderabad — February 07, 2012 — The ninth edition of BioAsia, the annual global bio business forum, is slated to get underway from February 09,…
GVK BIO Announces Multi-year Drug Discovery Collaboration
Hyderabad, India — November 28, 2011 — GVK Biosciences (GVK BIO), Asia’s leading drug discovery research & development organization, announced today that it has entered…
GVK Biosciences Presented the Frost & Sullivan Growth Leadership Award in the Contract Research Service Market
Hyderabad — November 21, 2011 — GVK Biosciences (GVK BIO), Asia’s leading drug discovery research and development organization, announced that it was awarded the Frost…
GVK Biosciences Partners with the PROOF Centre of Excellence, University of British Columbia in Biomarker Development and Commercialization
Hyderabad, India — November 15th, 2011 — GVK Biosciences (GVK BIO), Asia’s leading drug discovery research and development organization, announced today a new partnership with…
GVK Biosciences Extends the License of its SAR Databases to Astellas Pharma
Hyderabad, India — October 24, 2011 — GVK Biosciences (GVK BIO), Asia’s leading drug discovery research & development organization, announced today that Astellas Pharma Inc….
Indiana CTSI Partners with GVK Biosciences to Provide National Access to Biomarker Database
June 08, 2011 — In an agreement facilitated by the Indiana Economic Development Corporation (IEDC) during a February economic mission to India, the Indiana Clinical…
